NCT02448485Completed
High-Sensitivity Troponin T Plasma Levels in Patients With Aortic Stenosis (Tyrolean Aortic Stenosis Study-2)
High-Sensitivity Troponin T Plasma Levels in Patients With Aortic Stenosis
Source: ClinicalTrials.gov · Last updated 8 Oct 2026
Brief summary (registry, in English)
TASS-2 (Tyrolean Aortic Stenosis Study-2) aims to characterize the clinical value of minimally elevated troponin T plasma levels both in patients with asymptomatic and symtomatic aortic stenosis.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 10000 (estimated)
- First submitted
- 15 May 2015
- Start date
- 1 Jun 2015
- Primary completion date
- 31 Oct 2025
- Lead sponsor
- Medical University Innsbruck
- Diseases
- Heart failure, Coronary artery disease
- NCT number
- NCT02448485
What you commit to
- Study type: Observational
- Planned participants: 10000
- From 1 Jun 2015 to the primary completion date, 31 Oct 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- acute coronary syndrome
Other
- endocarditis
Who the study is looking for
- aortic stenosis detected by echocardiography / invasively
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Medical University Innsbruck Coordinator of this site? Confirm its status | Innsbruck | Austria | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.